FDA Advises Against Actimmune for IPF - Division of Pulmonary, Allergy, Critical Care & Sleep Medicine

jump to content sitemap

Division of Division of Pulmonary, Allergy, Critical Care & Sleep Medicine : Department of Internal Medicine : College of Medicine : The Ohio State University
http://internalmedicine.osu.edu/cardiovascular//pulmonary/7860.cfm

Home

FDA Advises Against Actimmune for IPF

	:: About the Division ::
	Welcome from the Director
	Alumni Information
	Best Doctors in America®
	Faculty Opportunities
	Faculty in the News

	2008
	2007
	2006
	2005
	2004
	History of the Division

Home > About the Division > Faculty in the News > 2007 > FDA Advises Against Actimmune for IPF

FDA Advises Against Actimmune for IPF
Chest Physician
04/2007

Dr. Clay Marsh offered his perspective on the complexity of IPF and the need to conduct adequately powered trials to determine if there is an effective treatment.

To read the entire article, click here.


*Department of Internal Medicine*	http://www.internalmedicine.osu.edu

	The Ohio State University \| College of Medicine Department of Internal Medicine Division of Pulmonary, Allergy, Critical Care & Sleep Medicine 201 DHLRI \| 473 W. 12th Avenue \| Columbus, OH 43210 Ph: 614.293.4925 \| Contact Us